科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/03/04 | 1,627 | 1,690 | 1,627 | 1,675 | +44 | +2.7% | 905,000 |
2013/03/01 | 1,605 | 1,642 | 1,585 | 1,631 | +18 | +1.1% | 521,000 |
2013/02/28 | 1,605 | 1,625 | 1,578 | 1,613 | +10 | +0.6% | 638,000 |
2013/02/27 | 1,625 | 1,636 | 1,598 | 1,603 | -30 | -1.8% | 523,000 |
2013/02/26 | 1,631 | 1,642 | 1,615 | 1,633 | +4 | +0.2% | 411,000 |
2013/02/25 | 1,560 | 1,640 | 1,560 | 1,629 | +75 | +4.8% | 787,000 |
2013/02/22 | 1,530 | 1,557 | 1,521 | 1,554 | +18 | +1.2% | 608,000 |
2013/02/21 | 1,535 | 1,555 | 1,535 | 1,536 | -9 | -0.6% | 336,000 |
2013/02/20 | 1,545 | 1,550 | 1,525 | 1,545 | +6 | +0.4% | 358,000 |
2013/02/19 | 1,504 | 1,549 | 1,501 | 1,539 | +45 | +3% | 433,000 |
2013/02/18 | 1,469 | 1,503 | 1,468 | 1,494 | +17 | +1.2% | 265,000 |
2013/02/15 | 1,469 | 1,482 | 1,460 | 1,477 | +12 | +0.8% | 493,000 |
2013/02/14 | 1,469 | 1,481 | 1,464 | 1,465 | -11 | -0.7% | 291,000 |
2013/02/13 | 1,475 | 1,497 | 1,466 | 1,476 | +2 | +0.1% | 269,000 |
2013/02/12 | 1,466 | 1,485 | 1,466 | 1,474 | +10 | +0.7% | 290,000 |
2013/02/08 | 1,450 | 1,478 | 1,438 | 1,464 | +15 | +1% | 347,000 |
2013/02/07 | 1,475 | 1,487 | 1,431 | 1,449 | -27 | -1.8% | 540,000 |
2013/02/06 | 1,532 | 1,532 | 1,466 | 1,476 | -53 | -3.5% | 555,000 |
2013/02/05 | 1,507 | 1,539 | 1,500 | 1,529 | +34 | +2.3% | 425,000 |
2013/02/04 | 1,503 | 1,511 | 1,487 | 1,495 | -7 | -0.5% | 220,000 |
2013/02/01 | 1,500 | 1,506 | 1,488 | 1,502 | +1 | +0.1% | 250,000 |
2013/01/31 | 1,482 | 1,506 | 1,466 | 1,501 | +24 | +1.6% | 336,000 |
2013/01/30 | 1,476 | 1,483 | 1,460 | 1,477 | +19 | +1.3% | 350,000 |
2013/01/29 | 1,430 | 1,470 | 1,429 | 1,458 | +28 | +2% | 369,000 |
2013/01/28 | 1,431 | 1,444 | 1,427 | 1,430 | -2 | -0.1% | 278,000 |
2013/01/25 | 1,395 | 1,436 | 1,395 | 1,432 | +37 | +2.7% | 278,000 |
2013/01/24 | 1,367 | 1,395 | 1,366 | 1,395 | +28 | +2% | 174,000 |
2013/01/23 | 1,359 | 1,375 | 1,358 | 1,367 | -1 | -0.1% | 181,000 |
2013/01/22 | 1,364 | 1,386 | 1,357 | 1,368 | -1 | -0.1% | 234,000 |
2013/01/21 | 1,371 | 1,379 | 1,366 | 1,369 | -2 | -0.1% | 166,000 |
2013/01/18 | 1,353 | 1,376 | 1,353 | 1,371 | +9 | +0.7% | 492,000 |
2013/01/17 | 1,353 | 1,371 | 1,353 | 1,362 | -14 | -1% | 388,000 |
2013/01/16 | 1,384 | 1,390 | 1,364 | 1,376 | -1 | -0.1% | 334,000 |
2013/01/15 | 1,344 | 1,382 | 1,344 | 1,377 | +42 | +3.1% | 344,000 |
2013/01/11 | 1,352 | 1,361 | 1,333 | 1,335 | -8 | -0.6% | 422,000 |
2013/01/10 | 1,343 | 1,352 | 1,322 | 1,343 | ±0 | ±0% | 237,000 |
2013/01/09 | 1,324 | 1,349 | 1,324 | 1,343 | +21 | +1.6% | 317,000 |
2013/01/08 | 1,301 | 1,331 | 1,301 | 1,322 | +16 | +1.2% | 244,000 |
2013/01/07 | 1,315 | 1,320 | 1,303 | 1,306 | -6 | -0.5% | 216,000 |
2013/01/04 | 1,287 | 1,313 | 1,287 | 1,312 | +41 | +3.2% | 309,000 |
2012/12/28 | 1,279 | 1,285 | 1,266 | 1,271 | -18 | -1.4% | 193,000 |
2012/12/27 | 1,293 | 1,299 | 1,284 | 1,289 | -2 | -0.2% | 166,000 |
2012/12/26 | 1,287 | 1,298 | 1,282 | 1,291 | +4 | +0.3% | 136,000 |
2012/12/25 | 1,299 | 1,303 | 1,286 | 1,287 | -12 | -0.9% | 206,000 |
2012/12/21 | 1,308 | 1,310 | 1,297 | 1,299 | -9 | -0.7% | 312,000 |
2012/12/20 | 1,296 | 1,315 | 1,295 | 1,308 | +14 | +1.1% | 408,000 |
2012/12/19 | 1,289 | 1,295 | 1,281 | 1,294 | +6 | +0.5% | 374,000 |
2012/12/18 | 1,279 | 1,295 | 1,274 | 1,288 | +25 | +2% | 347,000 |
2012/12/17 | 1,256 | 1,271 | 1,251 | 1,263 | +7 | +0.6% | 228,000 |
2012/12/14 | 1,254 | 1,290 | 1,253 | 1,256 | -9 | -0.7% | 272,000 |
3051~
3100
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 388,200円 | -6.4% | -71.8% | 4.89% | 43.23倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
サンバイオ | 253,000円 | - | - | 0.00% | - | 117.18倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.46倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 267,000円 | +21.7% | +999.9% | 0.00% | 12.30倍 | 4.21倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム